Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


BIO Lays Ethical Foundation For Change In Off-Label Communications

Executive Summary

The industry group's future advocacy around legal and regulatory reforms affecting product sponsor communications with payers and health-care providers will align with four bioethical considerations.


Related Content

How To Handle Off-Label Promotion: A Guide From PhRMA And BIO
Off-Label Communication Principles From PhRMA, BIO Aim For Reg Changes
Device Firms Should Not Ignore Pharma Off-Label Suits, Experts Say





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts